It is well known that disease is not necemsarily associated with experimentally induced or naturally occurring viral infection. Indeed, in recent years, considerable attention has been directed to the possible lack of direct relationship between viral multiplication and the formation of lesions. Sugg (1949) found that eggpropagated but mouse-unadapted influenza virus produced pneumonia in mice on primary inoculation, but despite active viral multiplication in the lung, lesions were not produced on subsequent passage in mice. He later showed (Sugg, 1950) that the production of pneumonia correlated with the infective titer of virus present in the lung. Extensive studies with pneumonia virus of mice (Horsfall and Ginsberg, 1951) and influenza A virus (Ginsberg and Horsfall, 1952) showed that gross lesions appeared only after extensive viral multiplication and that the rate of production of pulmonary lesions was slower than the rate of production of new virus particles. Ginsberg (1951) and Davenport (1952) , independently, studied the nontransmissible pneumonia induced in mice by Newcastle disease virus (NDV) and concluded that this pulmonary lesion resulted solely from the injurious or toxic action of a large amount of virus.
Selective inhibition by xerosin of pneumonia produced in mice by the pneumotoxicity of Newcastle disease virus (Group6, et al., 1953) and by mouse unadapted (Ginsberg, 1955) and mouse adapted influenza virus (Group6, et al., 1952) in the absence of demonstrable anti-viral effects provided additional evidence pertinent to the role of viral toxicity in the development of 1 These investigations were supported in part by Grants-in-aid from The National Microbiological Institute, National Institute of Health (E-811), the Roche Anniversary Fund, and by funds provided by the Rutgers Research and Endowment Foundation.
lesions. The fact that xerosin was also found to suppress pneumonia induced in mice by a chemical irritant such as the capsular polysaccharide of Klebsiella pneumoniae (Ginsberg, 1955) led to the investigation of the anti-inflammatory properties of xerosin. Waksman and Group6 (1956) showed that xerosin was, indeed, a potent anti-inflammatory agent that suppressed the tuberculin reaction, inflammation induced by turpentine or urease, and the diffusion of die in guinea pig skin but that it did not affect the histamine wheal and flare. These activities were shown to be strikingly similar to those of cortisone and its derivatives. However, cortisone has been found to be ineffective against pneumonia produced in mice by Newcastle disease virus or mouse unadapted influenza virus (Ginsberg, 1955) and generally to decrease resistance of the host to viral infection (Kass and Finland, 1953) .
The data presented in this report concern certain comparative anti-inflammatory properties of hydrocortisone, xerosin, and a derived pyridopyrimidine (DPP) which was found by Selitto and Randall (1956) to suppress yeast-induced inflammation in the rat ankle. In the interest of brevity and clarity the toxic factors associated with Newcastle disease virus and influenza virus will be referred to tentatively as NDV pneumotoxin and influenza neurotoxin.
MATERIALS AN] METHODS
Newcas diease virus (NDV) pneumotoxin. The California strain of NDV was propagated in the allantoic cavity of embryonated eggs in the usual manner and infected allantoic fluid was collected from both dead and living (refrigerated overnight) embryos 48 hr after infection. In the early experiments undiluted allantoic fluid was used for intranasal instillation. In later experi- Effect of zerosin on pneumonia produced in of 15 mice each mice by E. coli endotoxin. Figure 2 summarizes ).1 ml amounts of data showing that xerosin effectively suppressed otoxin and saline the extent of the lesion and reduced the weight e were killed on of the lungs. In this experiment 120 mice each im of pneumonia were inoculated intranasally with 250 ,ug of were then care-endotoxin. Two hours later and daily thereafter )rmalin. Paraffin half of the mice were injected subcutaneously up were prepared with 1.0 mg each of xerosin. The remaining half and eosin in the were injected with saline. Subgroups of 15 mice ins were indistin-from each group were selected at random and y NDV. Sharply placed in cages previously marked with the areas of hepati-scheduled date of sacrifice and examination. One ng one or more subgroup from the control and xerosin-treated :cised lungs were group were sacrificed each day from the second heir weight was through the sixth day after instillation of endoistologically, the toxin and the lesion scores and average weight desquamation of of the lungs were recorded. Alectasis, marked Figure 3 , 1953) . Attention should also be drawn to the fact that Jawetz (1954, personal communication) found that parenteral injection of xerosin failed to affect mortality in mice inoculated intraperitoneally with endotoxin and that parenteral injections of xerosin also failed to affect mortality following intravenous inoculation of influenza viral toxin (Groupe and Herrmann, 1955) . Figure 4 summarizes 6 representative experiments in which the anti-inflammatory properties of hydrocortisone, DPP, and xerosin were compared. In each of these experiments groups of 100 or more mice each were inoculated intranasally with 250 ,ug of endotoxin or with NDV pneumotoxin. were obtained in these systems only with dosage levels of 250 mg per kg or less. All mice were sacrificed on the third or fourth day after instillation of toxin and the lesion score and average weight of the lungs were recorded. The lesion scores paralleled the average weight of the lungs and the former have been omitted in the interest of brevity. The data show that: (a) All 3 preparations effectively suppressed pulmonary consolidation produced by endotoxin; (b) DPP and xerosin suppressed pneumonia produced by NDV but hydrocortisone failed to do so; (c) the minimal effective daily dose of DPP (300 mg per kg was also the maximum tolerated dose) was 6 times greater than that of hydrocortisone or xerosin; and (d) partly purified xerosin was as potent as crystalline hydrocortisone. Additional similar experiments showed that cortisone was as effective as hydrocortisone in suppressing pneumonia produced by endotoxin. Experiments vith influenza virus neurotoxin in mice. Since it has been shown that parenteral injections of xerosin delayed the onset of induced convulsions in mice previously inoculated intracerebrally with influenza virus neurotoxin (Group6 and Herrmann, 1955) , experiments similar in design and detail were carried out with hydrocortisone and DPP. Daily subcutaneous injections of 50 mg per kg of hydrocortisone begun 2 days before intracerebral inoculation of 1, 2, or 4 tonic convulsive doses of influenza virus neurotoxin failed to delay the onset of convulsions induced by twirling the mice. However, daily subcutaneous injections of 300 mg per kg of DPP begun 1 hr after intracerebral injection of 2-4 tonic convulsive doses of viral neurotoxin resulted in a small but definite delay in the onset of induced convulsions (about 10 hr). Thus, it would appear that DPP and xerosin again parallel one another and differ from hydrocortisone in their effects on this type of hostresponse to viral toxicity.
DISCUSSION
The comparative effects of cortisone, xerosin, and DPP in various diverse biological systems are briefly summarized in table 1. It is clear that all 3 preparations are effective anti-inflammatory agents. The failure of cortisone to suppress pulmonary lesions induced by viruses when the same lesions were beneficially modified by both xerosin and DPP is of particular interest. These data imply either that (a) pulmonary (1) See text. (2) See review by Kass and Finland (1953) . (3) Ginsberg (1955) . (4) Groupe and Herrmann (1955) . (5) Group6, Pugh, and Levine (1952) . (6) ibid (1953) . (7) Group6, Rauscher, and Bryan (1956a) . (8) consolidation instigated by these viruses is accomplished by a mechanism which is basically different from that initiated by certain other agents as suggested by Ginsberg (1955) , or that (b) the failure of cortisone to suppress lesions produced by viruses is associated with the profound adverse effects of large amounts of cortisone on the physiological state of the host which might also preclude the administration of a 608 [VOL. 72 sufficient quantity of cortisone to be effective against NDV-induced pneumonia. The fact that DPP, as well as xerosin, were effective in suppressing pneumonia induced by both NDV and bacterial endotoxin favors the latter interpretation. The failure of xerosin to protect mice against the intravenous injection of influenza virus is consistent with the failure of cortisone to protect mice against the intraperitoneal injection of bacterial endotoxin. These data are also consistent with the observation of Ginsberg (1955) who found that xerosin permitted clear definition of at least 2 distinct phases in the pathogenesis of influenza viral pneumonia in mice: (1) Injury by virus of the bronchial and bronchiolar epithelium which was unaffected by xerosin, and (2) secondary reactions leading to edema, hemorrhage, and cellular infiltration manifested as pneumonia which were inhibited by xerosin.
8U1MARY
Daily parenteral injections of hydrocortisone, a derived pyridopyrimidine (DPP), or the bacterial product, xerosin, suppressed pneumonia produced in mice by Escherichia coli endotoxin. However, only DPP and xerosin suppressed pneumonia induced by the toxicity of Newcastle disease virus (NDV) and delayed the onset of convulsions induced by influenza virus neurotoxin. It is not clear whether the failure of cortisone to affect NDV-induced pneumonia is associated with basic differences between such virus-induced lesions and other inflammatory responses or with the untoward effects of large amounts of hydrocortisone on the host.
